14-day Premium Trial Subscription Try For FreeTry Free
$27.36
+0.310 (+1.15%)
At Close: Jun 21, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Bridgebio Pharma Inc. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -24.89. In total, the insiders bought 1 295 234 and sold 2 586 640 BBIO shares in the last 100 trades.

Insider Power

(Last 100 transactions) 		-24.89
Buy 1 295 234 Shares
Sell 2 586 640 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 04, 2024 Common Stock Sell Scott Randal W. 1 500
Jun 03, 2024 Common Stock Sell Scott Randal W. 800
Jun 03, 2024 Common Stock Sell Scott Randal W. 200
May 16, 2024 Common Stock Buy Kumar Neil 60 667
May 16, 2024 Common Stock Sell Kumar Neil 30 748
May 16, 2024 Restricted Stock Units Sell Kumar Neil 33 544
May 16, 2024 Restricted Stock Units Sell Kumar Neil 19 599
May 16, 2024 Restricted Stock Units Sell Kumar Neil 2 394
May 16, 2024 Restricted Stock Units Sell Kumar Neil 5 130
May 16, 2024 Restricted Stock Units Sell Stephenson Brian C 17 368
May 16, 2024 Restricted Stock Units Sell Stephenson Brian C 6 704
May 16, 2024 Common Stock Buy Stephenson Brian C 27 507
May 16, 2024 Common Stock Sell Stephenson Brian C 13 943
May 16, 2024 Restricted Stock Units Sell Stephenson Brian C 947
May 16, 2024 Restricted Stock Units Sell Stephenson Brian C 778
May 16, 2024 Restricted Stock Units Sell Stephenson Brian C 1 710
Mar 12, 2024 Restricted Stock Units Buy Kumar Neil 313 588
Mar 12, 2024 Stock Option (right to buy) Buy Kumar Neil 45 140
Mar 12, 2024 Restricted Stock Units Buy Stephenson Brian C 107 278
Mar 12, 2024 Stock Option (right to buy) Buy Stephenson Brian C 15 442
Mar 01, 2024 Common Stock Sell Scott Randal W. 2 500
Feb 16, 2024 Restricted Stock Units Sell Stephenson Brian C 17 369
Feb 16, 2024 Common Stock Buy Stephenson Brian C 44 996
Feb 16, 2024 Common Stock Sell Stephenson Brian C 18 919
Feb 16, 2024 Restricted Stock Units Sell Stephenson Brian C 946
Click to get the best stock tips daily for free!

About Bridgebio Pharma Inc.

Bridgebio Pharma. BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabilizer of transthyretin, or TTR that is in Phase 3 clinical trial for the treatment of TTR amyloidosis-car... BBIO Profile

Golden Star

Ticker Date Change Price
V Jun 18 0.585% $273.62
EPD Jun 18 0.95% $28.30
USFD Jun 18 0.565% $53.14
INTC Jun 18 1.50% $30.63
UFPT Jun 18 3.45% $253.79
^DJI Jun 18 0.81% 38,834.86 points
BR Jun 17 1.59% $197.65
SARK Jun 17 1.98% $30.34
RGA Jun 17 1.62% $203.90
MA Jun 17 1.50% $448.11
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT